European Small Business Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Small Business Network.

Press releases published on August 12, 2026

Aug. 12, 2026

Marchex Announces Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 12, 2026

AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 12, 2026

Dillard’s, Inc. to Report Second Quarter and Year-to-Date Results

Indeterminate GlobeNewswire

Aug. 12, 2026

BIO GREEN MED SOLUTION REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Indeterminate GlobeNewswire

Aug. 12, 2026

Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million

Indeterminate GlobeNewswire

Aug. 12, 2026

Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide

Indeterminate GlobeNewswire

Aug. 12, 2026

Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

Aug. 12, 2026

OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth

Indeterminate GlobeNewswire

Aug. 12, 2026

Robinhood Markets, Inc. Reports July 2026 Operating Data

Indeterminate GlobeNewswire

Aug. 12, 2026

SKYX Reports 14% Growth and Record Sales of $25.3 Million in Q-2 2026 Compared to $22.1 Million in Q-1 2026 and 10 Consecutive Quarters of Growth YoY and as It Continues to Grow Its Market Penetration

Indeterminate GlobeNewswire

Aug. 12, 2026

Kailera Reports Second Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Aug. 12, 2026

Perma-Fix Reports Second Quarter 2026 Results, Award of Hanford Master IDIQ Subcontract and Commencement of DFLAW Waste Receipts

Indeterminate GlobeNewswire

Aug. 12, 2026

Enovix Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire

Aug. 12, 2026

Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China

Indeterminate GlobeNewswire

Aug. 12, 2026

ITG, Inc. Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire

Aug. 12, 2026

Forward Industries Reports Fiscal Third Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

Aug. 12, 2026

RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth

Indeterminate GlobeNewswire

Aug. 12, 2026

Comscore Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire

Aug. 12, 2026

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Microvast Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MVST

Indeterminate GlobeNewswire

Aug. 12, 2026

OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

Indeterminate GlobeNewswire